Geistlich launches advanced collagen membrane
Wolhusen/Schlieren - The regeneration specialist Geistlich Pharma has presented its advanced collagen membrane, the Geistlich Bio-Gide Forte, at the International Osteology Symposium (IOS). The launch is part of a global portfolio expansion.
Geistlich Pharma AG from Wolhusen in the canton of Lucerne, which is part of the Geistlich Group in Schlieren in the canton of Zurich, has presented new innovations in the field of regenerative medicine at the International Osteology Symposium (IOS) in Vienna. In a statement, the company particularly highlights the collagen membrane Geistlich Bio-Gide Forte, which is now also available on the European market following successful feedback from the USA.
Geistlich Bio-Gide Forte is a collagen membrane for reliable bone regeneration and optimal tissue integration with a natural bilayer collagen structure, the company explains. In comparison with the tried and tested Geistlich Bio-Gide, the “Forte” variant is said to offer increased strength, improved stability and easy handling. The further development comes as part of Geistlich’s global portfolio expansion, which will see a total of 20 new products launched in more than 40 countries to market the company’s 175 year anniversary in 2026.
“As a Swiss family-owned regenerative technology company, responsibility and pioneering spirit is in our DNA. Our pioneering spirit will drive continuous innovation. And, responsibility for patients, for our partners, for science and for quality,” explains CEO Diego Gabathuler in the statement.
The IOS also reaffirmed Geistlichs commitment to promoting young emerging talent. The Next Generation Round Table program offers 67 selected clinicians between the ages of 30 and 42 from around the world the opportunity to embark on a three-year training program. Moreover, outstanding achievements in clinical practice were recognized on the IOS stage as part of the Rising Stars Case Competition.
